Mark Baker

With investors increasingly viewing hotels as a solid asset class strong corporate governance has never been more important

Activist investor calls for new board after Progenics merger try

Locked in a proxy tussle with activist investor Velan Capital, Progenics opted to sell out rather than negotiate. But Velan isn't giving up the fight.

Kyle Blankenship Oct 10, 2019 10:10am